A recent study conducted by our laboratory found upregulation of mTOR and Wnt signaling proteins in c-MET/EGFR resistant NSCLC cell lines, implying the role of alternative cell signaling pathways in TKI resistance [63]. The gene discussed is MET; the disease is non-small cell lung carcinoma.